Chinese Firm Builds Genomics Facility for Translational Research with PacBio as Major Platform
The Suqian Lakeside Pangu Gene Company in Tianjin, China, has established a new genomics facility for translational medicine research projects and will use the PacBio RS II as its major sequencing platform.